The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩2,295.19Fair value₩5,839.77Bull₩14,614.67
FairClose
52-week traded range
52W low ₩5,860.0052W high ₩7,320.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
OSANG HEALTHCARE CO.,LTD. closed at ₩6,410.00, 9.8% above the consensus fair value of ₩5,839.77 drawn from 9 valuation models.
Financial DNA score 42/100 — Average. P/E of 28.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩4,485.88
-30.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩10,254.01
+60.0%
√(22.5 × EPS × BVPS)
EPS=226, BVPS=20677.42
Graham Formula
₩14,614.67
+128.0%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩4,520.00
-29.5%
EPS × 20x (sector P/E)
EPS=226, Sector P/E=20x
Peter Lynch (PEG)
₩4,635.26
-27.7%
EPS × Growth% (PEG = 1 is fair)
EPS=226, g=20.5%
Dividend Discount (DDM)
₩6,922.80
+8.0%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=128.2, r=10%, g=8%
Book Value (P/B)
₩2,295.19
-64.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=20677.42, ROE=1.1%, g=6%, r=10%
Reverse DCF
₩6,410.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.9% | Historical: 20.5%
Margin of Safety
₩6,351.48
-0.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=8468.64, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.